SE7608929L - Guanidinderivat och sett for deras framstellning - Google Patents

Guanidinderivat och sett for deras framstellning

Info

Publication number
SE7608929L
SE7608929L SE7608929A SE7608929A SE7608929L SE 7608929 L SE7608929 L SE 7608929L SE 7608929 A SE7608929 A SE 7608929A SE 7608929 A SE7608929 A SE 7608929A SE 7608929 L SE7608929 L SE 7608929L
Authority
SE
Sweden
Prior art keywords
compounds
bicyclo
guanide
individuals
rhinoviruses
Prior art date
Application number
SE7608929A
Other languages
English (en)
Swedish (sv)
Inventor
D L Swallow
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE7608929L publication Critical patent/SE7608929L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
SE7608929A 1975-08-11 1976-08-10 Guanidinderivat och sett for deras framstellning SE7608929L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33435/75A GB1492678A (en) 1975-08-11 1975-08-11 Guanidine derivatives

Publications (1)

Publication Number Publication Date
SE7608929L true SE7608929L (sv) 1977-02-12

Family

ID=10352924

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608929A SE7608929L (sv) 1975-08-11 1976-08-10 Guanidinderivat och sett for deras framstellning

Country Status (17)

Country Link
JP (1) JPS5225743A (Direct)
AT (1) AT351045B (Direct)
AU (1) AU497534B2 (Direct)
BE (1) BE845052A (Direct)
CA (1) CA1087180A (Direct)
CH (1) CH625207A5 (Direct)
DE (1) DE2635932A1 (Direct)
DK (1) DK362576A (Direct)
FI (1) FI762158A7 (Direct)
FR (1) FR2320736A1 (Direct)
GB (1) GB1492678A (Direct)
IE (1) IE43488B1 (Direct)
NL (1) NL7608903A (Direct)
NO (1) NO143993C (Direct)
PL (1) PL98956B1 (Direct)
SE (1) SE7608929L (Direct)
ZA (1) ZA764126B (Direct)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA814307B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
GB2113678B (en) * 1981-12-23 1985-06-19 Nat Res Dev Prostaglandins
DE3249514T1 (de) * 1982-06-21 1984-05-17 Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Arzneimittel mit antikarzinogener Wirkung
WO2005095345A2 (en) * 2004-03-23 2005-10-13 Achillion Pharmaceuticals, Inc. Heteroaryl guanidines as inhibitors of viral replication

Also Published As

Publication number Publication date
AU497534B2 (en) 1978-12-14
CH625207A5 (en) 1981-09-15
NO143993B (no) 1981-02-16
ATA592976A (de) 1978-12-15
AT351045B (de) 1979-07-10
GB1492678A (en) 1977-11-23
DE2635932A1 (de) 1977-03-03
JPS5225743A (en) 1977-02-25
NL7608903A (nl) 1977-02-15
CA1087180A (en) 1980-10-07
PL98956B1 (pl) 1978-06-30
FR2320736A1 (fr) 1977-03-11
ZA764126B (en) 1977-06-29
NO762774L (Direct) 1977-02-14
DK362576A (da) 1977-02-12
IE43488L (en) 1977-02-11
BE845052A (fr) 1977-02-10
AU1595676A (en) 1978-01-19
FI762158A7 (Direct) 1977-02-12
NO143993C (no) 1981-05-27
IE43488B1 (en) 1981-03-11
FR2320736B1 (Direct) 1980-11-07

Similar Documents

Publication Publication Date Title
Tarail Relation of abnormalities in concentration of serum potassium to electrocardiographic disturbances
KR900001677A (ko) 비아릴 화합물
ATE84967T1 (de) Verwendung von pentoxifyllin zur behandlung entzuendlicher erkrankungen.
ES515936A0 (es) "procedimiento de preparacion de derivados de xantina".
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
UA45497C2 (uk) Імуномодулятор з антимікробною і антимікобактеріальною активністю, спосіб його одержання і лікарський препарат для лікування мікробактеріозів, хронічних неспецифічних захворювань легенів, захворювань, що передаються статевим шляхом, і імунодефіциту на його основі
FR2455890A1 (fr) Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences
FR2398072A1 (fr) Acides et sels d'acides (n-carboxyalkyl-amino)-alcane-polyphosphoniques utilisables comme agents complexants
SE7608929L (sv) Guanidinderivat och sett for deras framstellning
DK0532566T3 (da) Cyklopentadienylcarbonyl-99mTc-komplekser, fremgangsmåde til fremstilling af disse samt deres anvendelse i diagnostikken
ATE78824T1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
Tanis Lead poisoning in children: including nine cases treated with edathamil calcium-disodium
SE8700555L (sv) Purinderivat, deras framstellning och lekemedel innehallande dessa
NO173137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
ES460621A1 (es) Procedimiento de sintesis de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida.
ES477302A1 (es) Procedimiento para la preparacion de bencenosulfonilureas.
DE69130146D1 (de) Einschlusskomplexe des 3-morpholino-sydnonimins oder seine salze oder seine isomeren tautomere, verfahren zur herstellung dieser komplexe und pharmazeutische zusammensetzungen die diese komplexe enthalten
FR2385672A1 (fr) Procede de preparation d'halogeno-cyclobutanones
KEITH et al. Subacute bacterial endocarditis due to hemolytic streptococci of Lancefield group G
FR2342972A2 (fr) Derives de la purine utilisables comme medicaments pour le traitement d'infections virales
ES8200684A1 (es) Procedimiento para la preparacion de sulfonilureas
Kohn Haemadsorption by measles syncytia
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
Bleumink et al. Allergic contact dermatitis to dinitolmide

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7608929-1